2Parks SB,Popovich RD.Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and ironoverload phenotypes[J].Am J Clin Pathol,2001,115:439.
3Lok AS,Heathcore FJ,Hoofnagle JH.Management of hepatitis B :2000.summary of a workshop[J].Gastroenterology,2001,120:1828.
4Brachtbuchf K,Wallery SA,Dusheiko GM,et al.A rapid real-time quantitative polymerase chain reaction for hepatitis B virus[J].J Virol Methods, 2001,93:105.
8Xiao SY, Wang HL, Hart J, et al. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol, 159: 1415-1421.
9Graveel CR, Jatkoe T, Madore SJ, et al. Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene, 2001, 20: 2704-2712.
10Okabe H, Satoh S, Kato T, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res, 2001, 61:2129-2137.
6Manzillo G, Piccinino F, Surrenti C, et al. Multicentredouble-blind placebo-controlled study of intravenous and oral s-Adenosyl-L-Methionine (SAMe) in cholestatic pa- tients with liver disease [J]. Drug Investigation, 4 (Suppl 4), 1992:90.
7Frezza M, Surrenti C, Manzillo G, et al. Oral S-adeno- sylmethionine in the symptomatic treatment of intrahepat- ic cholestasis. A double-blind, placebo-controlled study [J]. Gastroenterology, 1990,99 ( 1 ) : 211.
8Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version5.1.0[updated March 2011 ]. The Cochrane Collaboration, 2011 [EB/OL]. httla://www.cochrane-handbook.org.2011-04-06.
